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INTRODUCTION 
Atenolol has a low solubility 
characteristic in water and gastric fluid
Poorly soluble drugs  the 
rate of absorption is often 
controlled by the rate of 
dissolution
Inclusion complex to 
enhance the dissolution of 
atenolol
β-cyclodextrin
Inclusion complex of atenolol-β-
cyclodextrin 







Inclusion complex of 
atenolol-β-cyclodextrin Hypertension therapy
Geriatric patient
Inconvenient to use 
conventional tablets
Orally Disintegrating Tablets
FORMULA OF ATENOLOL-β-CYCLODEXTRIN 
ORALLY DISINTEGRATING TABLETS












Equal with 25 mg of 
atenolol
METHOD
Preparation of atenolol-β-cyclodextrin inclusion complex
Atenolol β-cyclodextrin
Mixed for 5 minutes and sieved 
through sieve no. 60
















Mixing of the inclusion complex and 
excipients
Pre compression evaluation
(flowability, compressibility, Hausner ratio, moisture content) 
Compression
Post compression evaluation
(% drug content, hardness, wetting time, water uptake ratio, in 
vitro dispersion time, friability, dissolution) 
RESULT AND DISCUSSION 
Scanning electron microscopy (SEM) images of inclusion complexes of atenolol with β-cyclodextrin 
(A) SEM image of atenolol (B) SEM image of β-cyclodextrin (C) SEM image of physical mixture of 
atenolol-β-cyclodextrin (D) SEM image of inclusion complex atenolol-β-cyclodextrin by kneading 
method (E) SEM image of inclusion complex atenolol-β-cyclodextrin by solvent evaporation 
method. 
RESULT AND DISCUSSION 
X-ray diffraction patttern of (A) atenolol (B) β-cyclodextrin (C) physical mixture of 
atenolol-β-cyclodextrin (D) inclusion complex of atenolol-β-cyclodextrin by 
kneading method (E) inclusion complex of atenolol-β-cyclodextrin by solvent 
evaporation method. 
RESULT AND DISCUSSION 
Infrared spectrum of inclusion complexes of atenolol with β-cyclodextrin (A) Infrared spectrum of atenolol 
(B) β-cyclodextrin (C) Physical mixture of atenolol-β-cyclodextrin (D) Inclusion complex of atenolol-β-
cyclodextrin by kneading method (E) Inclusion complex of atenolol-β-cyclodextrin by solvent evaporation 
method. 
RESULT AND DISCUSSION 
DSC thermogram of inclusion complexes of atenolol with β-cyclodextrin (A) Atenolol 
(B) β-cyclodextrin (C) Physical mixture of atenolol-β-cyclodextrin (D) Inclusion 
complex of atenolol-β-cyclodextrin by kneading method (E) Inclusion complex of 
atenolol-β-cyclodextrin by solvent evaporation method. 
RESULT AND DISCUSSION 
DRUG CONTENT 
PREPARATION OF INCLUSION COMPLEX % DRUG CONTENT
Physical Mixture 91,47±1,22 % 
Kneading Method 92,59±0,90 %
Solvent Evaporation Method 95,40%±0,97
RESULT AND DISCUSSION 
Dissolution profile of inclusion complex atenolol-β-cyclodextrin which made 
by physical mixture, kneading method, and solvent evaporation method. 
RESULT AND DISCUSSION 














RESULT AND DISCUSSION 
Wetting Time 
In Vitro Dispersion Time Test
Rapid disintegration without 
gel formation on the surface of 
tablets
RESULT AND DISCUSSION 
Parameter Results Spesification
Organoleptic Round white tablet, sweet 
and mint odor
Round white tablet, 
sweet and mint odor
Drug content (%) 100,01 ± 1,11 % 90,0-110,0%
Hardness (kg) 2,49 ± 0,41 kg 2-4 kg
Water absorption ratio (%) 54,72 ± 0,94 %
Disintegration time (seconds) 8,17 ± 0,41 seconds < 30 second
In vitro dispersion time (second) 45,33 ± 0,58 seconds
Friabilility (%) 0,26± 0,21 % < 1%
% Q (dissolution) 92,22 ± 0,41 seconds % Q > 85% in 30 
minutes
RESULT AND DISCUSSION 














- Solvent evaporation method produce the best physichochemical characteristics 
of inclusion complex of atenolol-β-cyclodextrin
- Orally disintegrating tablets of atenolol-β-cyclodextrin with sufficient mechanical 
strength, fast dispersion and disintegration time, and aceptable taste were 
produced from this study
- Orally disintegrating tablets of atenolol-β-cyclodextrin fulfill the dissolution 
specification
